Barry J. Marenberg

Barry J. Marenberg | Sills Cummis & Gross P.C.

The costs of developing new drugs are astounding. Estimates put the costs of developing new drugs in excess of $900 million and often approaches nearly 2 billion dollars for each new drug. This development cost, combined with the short remaining patent lifespan after regulatory approval, is the...

Marc S. Friedman, Barry J. Marenberg | Sills Cummis & Gross P.C.

The issue of patent marking is one that rarely appears before the Court of Appeals for the Federal Circuit. Recently, however, the Federal Circuit had the opportunity to decide a case dealing with false patent marking. The case is Clontech Laboratories, Inc. v. Invitrogen Corporation,1 a case in...